Results 141 to 150 of about 42,196 (203)
Hyaluronidase for microstomia in fibrosing skin disease: Systematic review and case series. [PDF]
JAAD IntZhu C +7 more
europepmc +1 more source
Halting hyaluronidase hopping to maintain the integrity of Medicare drug price negotiation. [PDF]
J Manag Care Spec PharmKim J, Kesselheim AS, Rome BN.
europepmc +1 more source
Systematic evaluation of pre-analytical variables on synovial fluid metabolomic profiles using GC-ToF-MS and UHPLC-MS. [PDF]
AnalystLadha Y +6 more
europepmc +1 more source
Ultrasound observational anatomical guideline for retrobulbar hyaluronidase injection. [PDF]
Anat Cell BiolYi KH +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
A Microplate Assay for Hyaluronidase and Hyaluronidase Inhibitors
Analytical Biochemistry, 1994A sensitive, high-throughput assay has been developed which measures hyaluronidase activity in a microplate format. In this assay, hyaluronic acid is suspended in agarose in a microtiter well, the plate is incubated with the hyaluronidase solution, and the undigested hyaluronic acid is precipitated with cetylpyridinium chloride.
J S, Tung, G E, Mark, G F, Hollis
openaire +2 more sources
Journal of Neurochemistry, 1972
Abstract— Hyaluronidase (hyaluronate glycanohydrolase, EC 3.2.1.35), with a pH optimum of 3.7, was detected in rat and bovine brain. It degraded hyaluronic acid and, at a slower rate, chondroitin sulphate to a mixture of higher oligosaccharides with N‐acetylhexosamine at the reducing end.
R U, Margolis +3 more
openaire +2 more sources
Abstract— Hyaluronidase (hyaluronate glycanohydrolase, EC 3.2.1.35), with a pH optimum of 3.7, was detected in rat and bovine brain. It degraded hyaluronic acid and, at a slower rate, chondroitin sulphate to a mixture of higher oligosaccharides with N‐acetylhexosamine at the reducing end.
R U, Margolis +3 more
openaire +2 more sources